Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 28;14(2):102.
doi: 10.3390/ph14020102.

Metabolite Profiling of Methanolic Extract of Gardenia jaminoides by LC-MS/MS and GC-MS and Its Anti-Diabetic, and Anti-Oxidant Activities

Affiliations

Metabolite Profiling of Methanolic Extract of Gardenia jaminoides by LC-MS/MS and GC-MS and Its Anti-Diabetic, and Anti-Oxidant Activities

Kandasamy Saravanakumar et al. Pharmaceuticals (Basel). .

Abstract

In this study, the methanolic extract from seeds of Gardenia jasminoides exhibited strong antioxidant and enzyme inhibition activities with less toxicity to NIH3T3 and HepG2 cells at the concentration of 100 µg/mL. The antioxidant activities (DPPH and ABTS), α-amylase, and α-glucosidase inhibition activities were found higher in methanolic extract (MeOH-E) than H2O extract. Besides, 9.82 ± 0.62 µg and 6.42 ± 0.26 µg of MeOH-E were equivalent to 1 µg ascorbic acid for ABTS and DPPH scavenging, respectively while 9.02 ± 0.25 µg and 6.52 ± 0.15 µg of MeOH-E were equivalent to 1 µg of acarbose for inhibition of α-amylase and α-glucosidase respectively. Moreover, the cell assay revealed that the addition of MeOH-E (12.5 µg/mL) increased about 37% of glucose uptake in insulin resistant (IR) HepG2 as compared to untreated IR HepG2 cells. The LC- MS/MS and GC-MS analysis of MeOH-E revealed a total of 54 compounds including terpenoids, glycosides, fatty acid, phenolic acid derivatives. Among the identified compounds, chlorogenic acid and jasminoside A were found promising for anti-diabetic activity revealed by molecular docking study and these molecules are deserving further purification and molecular analysis.

Keywords: GC-MS; Gardenia jasminoides Ellis; LC-MS/MS; anti-diabetic activity; anti-oxidant.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Cytotoxicity of the methanolic extract (MeOH-E) of G. jasminoides in NIH3T3 cell line (a), AO/EB staining assay (b). ** p < 0.01 significant. Scale bar 100 µm.
Figure 2
Figure 2
Cytotoxicity of the methanolic extract (MeOH-E) of G. jasminoides in insulin-resistant (IR) HepG2 cell line (a), glucose uptake (b), AO/EB staining assay (c), mitochondrial membrane potential (d), measurement of nucleus damage by PI (e), analysis of the reactive oxygen species generation (f). Scale bar 100 µm for C & E, and 50 µm for D & F. * p < 0.05, ** p < 0.01, *** p < 0.001 significant.
Figure 3
Figure 3
Structures of selected compounds identified by LC-MS/MS.
Figure 4
Figure 4
MS/MS spectrum of compounds identified from methanolic extract (MeOH-E) of G. jasminoides by LC-MS/MS analysis. Blue markings and the numbers in blue highlighter indicate the predicted MS/MS fragmentation of the compounds provided by MassFragment, an in silico fragmentation tool that uses a systematic bond disconnection approach to identify possible structures from the parent structure.
Figure 5
Figure 5
Molecular catalytic interaction of the compound identified from the methanolic extract (MeOH-E) of G. jasminoides with α amylase. Jasminoside F (a), chlorogenic acid (b), jasminoside A (c), thymine (d), acarbose derived trisaccharide (e), and acarbose (f) interacting with diabetes-related enzyme of α amylase (5E0F).
Figure 6
Figure 6
Molecular catalytic interaction of the compound identified from the methanolic extract (MeOH-E) of G. jasminoides with α glucosidase (5NN8). Jasminoside F (a), jasminoside B (b), chlorogenic acid (c), jasminoside A (d), acarbose derived trisaccharide (e), and acarbose (f) interacting with diabetes-related enzyme α glucosidase (5NN8).

References

    1. Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N., Colagiuri S., Guariguata L., Motala A.A., Ogurtsova K., et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843. - DOI - PubMed
    1. Behl T., Kotwani A. Anti-hyperglycemic effect of Terminalia catappa fruit extract in streptozotocin-induced diabetic rats. Int. J. Pharm. Pharm. Sci. 2017;9:212. doi: 10.22159/ijpps.2017v9i4.17593. - DOI
    1. Apoorva S.M., Sridhar N., Suchetha A. Prevalence and severity of periodontal disease in type 2 diabetes mellitus (non-insulin-dependent diabetes mellitus) patients in Bangalore city: An epidemiological study. J. Indian Soc. Periodontol. 2013;17:25–29. doi: 10.4103/0972-124X.107470. - DOI - PMC - PubMed
    1. Ram Niwas J., Gyan Chand J. Evaluation of Antidiabetic Activity of Hydroalcoholic Extract of Cassia fistula Linn. pod in Streptozotocin-Induced Diabetic Rats. Pharmacogn. J. 2017;9:599–606.
    1. Fargion S., Dongiovanni P., Guzzo A., Colombo S., Valenti L., Fracanzani A.L. Iron and insulin resistance. Aliment. Pharmacol. Ther. 2005;22:61–63. doi: 10.1111/j.1365-2036.2005.02599.x. - DOI - PubMed

LinkOut - more resources